Company profile: Market Access Transformation
1.1 - Company Overview
Company description
- Provider of an online platform and associated services that enable healthcare manufacturers and payers to exchange market access insights via surveys and clarification requests. Offerings include Rapid Payer Response (RPR), Manufacturer and Payer Portals, a global network of vetted healthcare stakeholders (Payer Network), Agile Payer Research, and payer insights on the acceptability of surrogate endpoints in clinical trials.
Products and services
- MAT Rapid Payer Response Platform (RPR): An online platform-based information exchange that delivers research and information sharing between manufacturers and payers via surveys and clarification requests, enabling real-world potential assessment
- Payer Network: A global network of healthcare stakeholders that supplies input on market access questions through surveys, allowing manufacturers to gather payer insights
- Manufacturer Portal: A MAT Platform section where manufacturers develop, manage, implement, and review surveys and related documents used in exchanges with payers
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Market Access Transformation
UNIConnect
HQ: United States
Website
- Description: Provider of software to manage complexity, offering flexible, scalable solutions that are rapidly implemented and ultimately placed.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full UNIConnect company profile →
Cyrus
HQ: United States
Website
- Description: Provider of protein design software and services, including the Rosetta software combining physics-based modeling and statistical patterns to design protein binders, de novo proteins, and assemblies; the Cyrus software platform with Rosetta protocols, AI, cloud workflow automation, and in-house structure/data analysis; services for protein design, deep mutational scanning, cytokine engineering; and Next Gen IdeS enzyme for IgG-mediated disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cyrus company profile →
CRIO
HQ: United States
Website
- Description: Provider of eSource technology and tools to streamline clinical research workflows, including a web-based system for direct data capture with real-time entry and monitoring, and Reviewer EDC, an interface integrating eSource with Electronic Data Capture to enable remote monitoring and data review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CRIO company profile →
N-SIDE
HQ: Belgium
Website
- Description: Provider of deeptech software and algorithms for life sciences and energy to improve decisions and optimize critical resources. Combines industry expertise with applied mathematics and AI. Products include Lighthouse, software for managing clinical trial supply chains to reduce waste, and a Power Matching Algorithm that optimizes supply and demand to determine day-ahead electricity prices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full N-SIDE company profile →
Atomwise
HQ: United States
Website
- Description: Provider of AI and deep learning–based, structure‑based drug discovery solutions, leveraging supercomputers to identify small‑molecule candidates. Offers AtomNet technology to streamline discovery and develop a pipeline of drug candidates advancing into preclinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atomwise company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Market Access Transformation
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Market Access Transformation
2.2 - Growth funds investing in similar companies to Market Access Transformation
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Market Access Transformation
4.2 - Public trading comparable groups for Market Access Transformation
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →